Journal of Addiction Medicine

Article	Citations
Alcohol Consumption in Response to the COVID-19 Pandemic in the United States	176
Opioid Use Disorder and COVID-19: Crashing of the Crises	137
Innovation During COVID-19: Improving Addiction Treatment Access	117
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update	106
Defining Low-threshold Buprenorphine Treatment	99
Gambling During the COVID-19 Crisis – A Cause for Concern	88
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report	64
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond	62
The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic: A Longitudinal Study	51
Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis	49
Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder	44
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	43
Recommended Use of Terminology in Addiction Medicine	42
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)	38
Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices?	36
Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study	36
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic	35
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management	34
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts	33
The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities	32
“Like Yin and Yang”: Perceptions of Methamphetamine Benefits and Consequences Among People Who Use Opioids in Rural Communities	32
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia: Consideration of Problem Gambling and Psychological Distress	32
Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration	31
Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study	31
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic	29

Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis	28
Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review	28
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report	27
Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review	25
Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons	25
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs	24
Hospital-based Buprenorphine Micro-dose Initiation	24
Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond	23
The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries	21
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach	21
Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing	20
Peer Recovery Support Services Across the Continuum: In Community, Hospital, Corrections, and Treatment and Recovery Agency Settings – A Narrative Review	20
“You’re Always Jumping Through Hoops”: Journey Mapping the Care Experiences of Individuals With Opioid Use Disorder-associated Endocarditis	20
Exercise Addiction Prevalence and Correlates in the Absence of Eating Disorder Symptomology: A Systematic Review and Meta-analysis	19
Cannabis-related Hospitalizations Among Youth in Canada Before and After Cannabis Legalization	19
Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder	19
Language Matters: It Is Time We Change How We Talk About Addiction and its Treatment	19
Medications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection	18
Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults	18
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs	18
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes	17
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey	17
Sociodemographic Characteristics and the Stigmatization of Prescription Opioid Addiction	17
Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic: A Qualitative Analysis	17
Can Individuals With Alcohol Use Disorder Sustain Non-abstinent Recovery? Non-abstinent Outcomes 10 Years After Alcohol Use Disorder Treatment	17
DEA Disconnect Leads to Buprenorphine Bottlenecks	17
Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study	16
Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism	16
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas	15
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	15
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use	15
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia	15
Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study	15
Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic	15
Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State Laws	14
During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio	14
Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication	14
Pills to Powder: A 17-Year Transition From Prescription Opioids to Heroin Among US Adolescents Followed Into Adulthood	14
Years of Life Lost due to Opioid Overdose in Ohio: Temporal and Geographic Patterns of Excess Mortality	14
Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description	14
Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge	14
Disparities in Documented Drug Use Disorders Between Transgender and Cisgender U.S. Veterans Health Administration Patients	13
Evaluation of Resident Physicians’ Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder	13
Executive Summary of the American Society of Addiction Medicine (ASAM) Clinical Practice Guideline on Alcohol Withdrawal Management	13
COVID-19 and Cannabidiol (CBD)	13
Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists	12
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	12
Alcohol Medical Intervention Clinic: A Rapid Access Addiction Medicine Model Reduces Emergency Department Visits	12
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	12
Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations	12

Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis	12
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	12
Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder	12
Adolescent SBIRT Practices Among Pediatricians in Massachusetts	12
Virtual Twelve Step Meeting Attendance During the COVID-19 Period: A Study of Members of Narcotics Anonymous	11
Suicide Behavior Following PHQ-9 Screening Among Individuals With Substance Use Disorders	11
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	11
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	11
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	11
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19	11
Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada	11
Changing Outdated Methadone Regulations That Harm Pregnant Patients	11
Potential Value of the Insights and Lived Experiences of Addiction Researchers With Addiction	11
Inconsistent Addiction Treatment for Patients Undergoing Cardiac Surgery for Injection Drug Use-associated Infective Endocarditis	11
Preferences for Tobacco Cessation Information and Support During Covid-19	11
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques	10
COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform	10
Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey	10
Urinary Buprenorphine, Norbuprenorphine and Naloxone Concentrations and Ratios: Review and Potential Clinical Implications	10
Geriatric Conditions Among Middle-aged and Older Adults on Methadone Maintenance Treatment: A Pilot Study	10
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	10
Addressing Missing Data in Substance Use Research: A Review and Data Justice-based Approach	10
Self-efficacy Mediates Perceived Benefits and Barriers of Adherence of Heroin-dependent Patients to Methadone for Addiction Treatment: A Health Belief Model Study	10
Use of a Telemedicine Bridge Clinic to Engage Patients in Opioid Use Disorder Treatment	10
Discharges “Against Medical Advice” in Patients With Opioid-related Hospitalizations	10
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies	10
Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?	10
Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report	10
A Pilot Crossover Trial of Sleep Medications for Sleep-disturbed Methadone Maintenance Patients	9
Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples	9
Pressure Necrosis Requiring Fasciotomy After Kratom Overdose	9
Calls for Access to Safe Injecting Supplies as a Critical Public Health Measure During the COVID-19 Pandemic	9
Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine	9
Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes	9
Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges	9
Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States	9
Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT	8
Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use	8
Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder	8
The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series	8
Rise in Presence of Methamphetamine in Oral Fluid Toxicology Tests Among Outpatients in a Large Healthcare Setting in the Northeast	8
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis	8
Civil Commitment for Substance Use Disorders: A National Survey of Addiction Medicine Physicians	8
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	8
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19	8
Do Sex Differences Among Adults With Opioid Use Disorder Reflect Sex-specific Vulnerabilities? A Study of Behavioral Health Comorbidities, Pain, and Quality of Life	8
Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic	8
Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19	8
Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial	7
False-positive Fentanyl Urine Detection after Initiation of Labetalol Treatment for Hypertension in Pregnancy: A Case Report	7
2021 Poster Abstracts	7
Gaps in Alcohol Screening and Intervention Practices in Surgical Healthcare: A Qualitative Study	7
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	7
Continuation in Treatment and Maintenance of Custody of Newborns After Delivery in Women With Opioid Use Disorder	7
Skin Necrosis Following Inadvertent Dermal Injection of Extended-release Buprenorphine	7
An Acute Care Contingency Management Program for the Treatment of Stimulant Use Disorder: A Case Report	7
Cannabis Use and Stroke: Does a Risk Exist?	7
Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder	7
Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19	7
Understanding Contraceptive Needs of Women Who Inject Drugs in Orange County: A Qualitative Study	7
Guidance for Writing Case Reports in Addiction Medicine	7
The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report	7
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	7
Utilization of Medications for Opioid Use Disorder Across US States: Relationship to Treatment Availability and Overdose Mortality	6
A Telemedicine Approach to Increase Treatment of Alcohol Use Disorder in Primary Care: A Pilot Feasibility Study	6
Poverty and Excess Length of Hospital Stay in Neonatal Opioid Withdrawal Syndrome	6
In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care	6
Opioid-related Emergency Department Visits During COVID-19 in a Large Health System	6
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis	6
Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders	6
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	6
A Proposal for Addiction and Infectious Diseases Specialist Collaboration to Improve Care for Patients With Opioid Use Disorder and Injection Drug Use-Associated Infective Endocarditis	6
The Role of Hospitalists in Treating Opioid Use Disorder	6
Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis	6
Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series	6
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA	6
Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study	6
The Potential Association Between Prenatal Cannabis Use and Congenital Anomalies	6
How Patient Centered Are Addiction Treatment Intake Processes?	6
Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review	6

COVID-19 Social Distancing and Online Mutual Help Engagement for Alcohol Use Recovery	6
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder	6
Evidence on Buprenorphine Dose Limits: A Review	6
“Nobody Knows How You’re Supposed to Interpret it:” End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts	6
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report	6
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	6
Exercise Addiction Stability and Health Effects. A 6-Month Follow-up Postcompetition Study in Amateur Endurance Cyclists	5
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later	5
Psychometric Properties of the Revised Clinical Institute Withdrawal Alcohol Assessment and the Brief Alcohol Withdrawal Scale in a Psychiatric Population	5
Medical Student Spirituality and Substance Use	5
Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing	5
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	5
Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance	5
Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment during COVID-19	5
Substance Use and Utilization of Prenatal and Postpartum Care	5
Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series	5
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	5
Statewide Availability of Buprenorphine/Naloxone in Acute Care Hospitals	5
Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis	5
Integrating Reproductive and Sexual Health Education and Services Into Opioid Use Disorder Treatment Programs: A Qualitative Study	5
Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut	5
Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women	5
Maternal Cannabis Use in the Perinatal Period: Data From the Pregnancy Risk Assessment Monitoring System Marijuana Supplement, 2016–2018	5
Extreme Binge Drinking During Adolescence: Associations With Subsequent Substance Use Disorders in American Indian and Mexican American Young Adults	5
Food Insecurity and Substance Use Among Young Adult College Students in the United States	5
Evaluation of the BEAT Meth Intervention for Emergency Department Patients with Methamphetamine Psychosis	5
The Naloxone Component of Buprenorphine/Naloxone: Discouraging Misuse, but at What Cost?	5
Factors Associated With Drug Overdoses During the COVID-19 Pandemic	5
Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People	5
Case Study: Naltrexone for the Treatment of Nitrous Oxide Use	5
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	5
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting	5
Prescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone	5
Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment	5
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment	5
Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic: Providers’ Leadership Efforts in Unprecedented Times	5
Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model	5
Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19	5
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	4
Factors Associated With Cannabis Use Among African American Nondaily Smokers	4
Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare System	4
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian Setting	4
The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance	4
HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic	4
Use of Injectable Opioid Agonist Therapy in a In-Patient Setting for a Pregnant Patient With Opioid Use Disorder: A Case Report	4
Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties	4
MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions	4
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	4
Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment	4
First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers	4
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	4
Challenges of Diagnosing and Managing Designer Benzodiazepine Dependence and Withdrawal: A Case Report	4
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	4
Take-Home Naloxone and the Need for a Publicly Funded Naloxone Supply	4
Nudging Emergency Department-Initiated Addiction Treatment	4
Opioid Use Behaviors Among People With Disability in the United States: An Analysis of the National Survey on Drug Use and Health	4
Use of Electronic Health Record Data to Estimate the Probability of Alcohol Withdrawal Syndrome in a National Cohort of Hospitalized Veterans	4
A Bridge Too Far: Individuals With Regular and Increasing Very Heavy Alcohol Consumption Cannot be Considered as Maintaining “Recovery” Due to Toxicity and Intoxication-related Risks	4
Opioid Use Disorder Treatment in the Fentanyl Era	4
Virtual Care in an Outpatient Subspecialty Substance Use Disorder Treatment Program	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Disability Discrimination Against People With Substance Use Disorders by Postacute Care Nursing Facilities: It is Time to Stop Tolerating Civil Rights Violations	4
Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment	4
Opting into the Public List of DATA-Waivered Practitioners: Variations by Specialty, Treatment Capacity, and Practitioner Characteristics	4
Dissemination of a Universally Delivered Brief Alcohol Intervention in United States Air Force Technical Training	4
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	4
Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report	4
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	4
What's in an “ASAM-based Assessment?” Variations in Assessment and Level of Care Determination in Systems Required to Use ASAM Patient Placement Criteria	4
Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers	4
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 – 2020	4
Opioid Use Disorder in the Emergency Department Amid COVID-19	4
Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs	4
Therapy Dose Mediates the Relationship Between Buprenorphine/Naloxone and Opioid Treatment Outcomes in Youth Receiving Medication for Opioid Use Disorder Treatment	4
Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial	4
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids	4
Internal Medicine Residents’ Feelings of Responsibility, Confidence, and Clinical Practice in Opioid Overdose Prevention and Naloxone Prescribing	4
Involuntary Commitment for Substance Use: Addiction Care Professionals Must Reject Enabling Coercion and Patient Harm	4
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report	4
Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?	4
Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation	4
A Case of False-positive Amphetamine Results on Urine Toxicology Testing Secondary to Imatinib	3
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	3
Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use Disorders	3
Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D	3
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	3
Association Between Patterns of Alcohol Use and Short-Term Risk of Suicide Attempt Among Patients With and Without Reported Suicidal Ideation	3
Perception of Resource Allocations to Address the Opioid Epidemic	3
Associations Among Childhood Household Dysfunction, Sexual Orientation, and DSM-5 Alcohol, Tobacco and Other Substance Use Disorders in Adulthood: Evidence From a National U.S. Survey	3
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	3
A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine	3
Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool	3
Defining Opioid-related Problems Using a Health Care Safety Net Institution’s Inpatient Electronic Health Records: Limitations of Diagnosis-based Definitions	3
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	3
Patterns of Prescription Opioid Use Prior to Self-reported Heroin Initiation	3